Your 15 Minute Workday… (Make Extra Cash from Home)
Some people binge watch Netflix… Hulu…or HBO shows. And some people turn their downtime into cash. James made $2,275 in just 19 minutes…all thanks to something called The 15 Minute Workday. The average trade makes 12% in just 5 days (factoring winners and losers) which is out of this world.
Click here to start
pixel

PAR Insider Trading (Paradigm Biopharmaceuticals)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Paradigm Biopharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Paradigm Biopharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Paradigm Biopharmaceuticals Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for PAR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel

Paradigm Biopharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/19/2020Christopher FullertonInsiderTransfer1,000,000A$3.05A$3,050,000.00
5/11/2020John GaffneyInsiderSell115,695A$2.37A$274,081.46
5/8/2020Graeme KaufmanInsiderSell184,216A$2.30A$423,696.80
4/23/2019Christopher FullertonInsiderBuy15,000A$1.65A$24,720.00
See Full Table
Insider Trading at Paradigm Biopharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Paradigm Biopharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Paradigm Biopharmaceuticals (ASX:PAR)

Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable form for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.
Read More on Paradigm Biopharmaceuticals

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

1,805,207 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Paradigm Biopharmaceuticals?

Paradigm Biopharmaceuticals' top insider investors include:
  1. Christopher Fullerton (Insider)
  2. Graeme Kaufman (Insider)
  3. John Gaffney (Insider)
10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel